Verona Pharma Plc - ADR
Search For a Symbol
Verona Pharma Plc - ADR Stock, NASDAQ:VRNA
3 More London Riverside, 3 More London Riverside, London, Greater London SE1 2RE
Number of Employees: 36
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.